About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
NeLM
news service
Santarus submits new drug application for Zegerid (omeprazole) chewable tablets
Source:
BioSpace.com
Date published:
31/05/2005 00:00
Summary
by:
Hina Radia
Santarus has announced that it has submitted a New Drug Application (NDA) for Zegerid (omeprazole) Chewable Tablets 40 mg and 20 mg to the U.S. Food and Drug Administration (FDA).
About this library entry
Category:
1.3.5 Proton pump inhibitors
|
Food &Drug Administration (FDA)
|
Helicobacter pylori
|
Stomach and duodenum
NeLM
area:
News
Link
Preview your comment
Add new comment
Comment text:
Comments
There are no comments yet. You could be the first!
You must be Logged In to comment.
Printer Friendly Version
Related evidence
1.3.5 Proton pump inhibitors
08/08/2011
Vimovo (esomeprazole and naproxen) primary care briefing (Aug 2011 update)
14/09/2010
SMC accepts esomeprazole granules for oral solution (Nexium®) for treatment of GORD in children (restricted use)
13/07/2010
SMC accepts ketoprofen/omeprazole combination preparation (Axorid®) for the symptomatic treatment of rheumatoid arthritis, ankylosing spondylitis and osteoarthritis
Helicobacter pylori
11/05/2007
Lansoprazole oro-dispersible tablet (Zoton FasTab®) for eradication of Helicobacter pylori - Abbreviated Submission
25/11/2004
NICE clinical guideline: Dyspepsia - Management of dyspepsia in adults in primary care
Stomach and duodenum
02/12/2010
DTB: Targinact (oxycodone plus naloxone)
18/01/2010
A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis
15/06/2007
Medical treatments in the short term management of reflux oesophagitis
Related news
1.3.5 Proton pump inhibitors
09/02/2012
FDA Safety Communication: Proton pump inhibitors and Clostridium Difficile-associated diarrhoea
01/02/2012
Prospective cohort study evaluates association between PPI use and risk of hip fracture in postmenopausal women
25/01/2012
RCT: Lansoprazole not effective for children with poorly controlled asthma
Helicobacter pylori
29/11/2011
Helicobacter pylori eradication may benefit those with functional dyspepsia?
20/07/2011
Trial evaluating 3 different H pylori eradication regimens shows 14-day triple therapy is most effective
11/03/2011
Sequential therapy vs. standard triple therapy for Helicobacter Pylori Eradication in children: RCT
Stomach and duodenum
22/04/2010
Prucalopride (Resolor®) launched in UK for treatment of chronic constipation in women
22/02/2007
Review: diabetic gastroparesis
15/11/2004
Patients with severe cirrhosis and upper GI bleeding may benefit from coagulation factor rFVIIa?
Back